March 30, 2026 | Pre- Congress Workshops

March 31 - April 2, 2026 | Main Congress Days

WALTER E. WASHINGTON CONVENTION CENTER, WASHINGTON D.C.

R&D + Strategic Partnering
for the Global Vaccine Industry

BOOK TICKET - 70% OFF

APPLY TO SPONSOR /EXHIBIT /SPEAK

WORLD’S LEADING VACCINE EVENT

4,000+

Attendees

550+

Speakers

300+

Exhibitors

100+

Start-ups

4

Days

12

Tracks

15

Workshops

2,500+

Partnering Meetings

The Most Important Vaccine Event of The Year

CONFERENCE

550+ SPEAKERS

Covering Clinical Development, Bioprocessing & Manufacturing, Cancer Immunotherapy and much more

APPLY TO SPEAK

EXHIBITION

MEET YOUR MARKET

300+ leading solution providers from across the globe, featuring new ways of thinking and novel partnerships to generate solutions

EXHIBIT / SPONSOR NOW

NETWORKING

IN-PERSON

Networking is at the heart of World Vaccine Congress Washington. Our congress allows you to connect directly with thousands of vaccine experts across 4 days of built-in 1-2-1 networking

GET YOUR TICKETS

The Start-to-Finish of Vaccines

From research, immune profiling & clinical trials to manufacture and access

Clinical Trials
Understand how to move your vaccine candidates through development phases to licensure

Immune Profiling
Explores recent efforts into infectious disease modelling, immune characterization and T/B cell interplay.

Pandemic Platforms
The most promising platforms that can be used for an outbreak, from pathogen adaptability to speed, scale up and implementation

Cancer & Immunotherapy
Cancer vaccines and the future of combination treatments

Supply & Logistics
Learn how we are dealing with the supply demands and the technologies that will allow last mile delivery

Vaccine Access
Understand the dynamics governing global vaccine markets & what interventions can be made for better access

Influenza & Respiratory
Latest updates in RSV, influenza, pneumococcal, pan- and combinational vaccines

Vaccine Safety
New tools to measure vaccine surveillance, safety and managing misinformation

Veterinary
A one health approach to battle emerging zoonotic diseases and climate change

Bioprocessing & Manufacturing
Meet with the manufacturers & bioprocessing experts to advance your vaccine formulation, tech transfer & scale-up

Partnerships
Secure funding and navigate through successful Public-Private-Partnerships with all stakeholders

Emerging & Re-Emerging Diseases
From Disease X preparedness, neglected diseases to global health vaccine development & new platforms

GET YOUR TICKETS

APPLY TO SPEAK

EARLY CONFIRMED 2026 SPEAKERS

David Burkhart
CEO
Inimmune Corp
Holger Kissel
Senior Vice President
Biontech
Charles Kline
Associate Vice President
Merck
Arvind Kumar
Vice President of Research
BiomEdit
Francesca Micoli
Director GVGH Innovation Academy and Senior Project Leader
GVGH
Mayur Patel
VP Global R&D Product Development and Portfolio Management
Elanco
Lora Shimp
Director - Immunization Center
John Snow Inc
Christian Harding
CSO & Co-founder
Omniose
Brian Abramson
Board of Directors
National Vaccine Law Association
Navneet Bichha
Senior Program Officer
The INCLEN Trust International

GET YOUR TICKETS

SEE SPEAKER LIST

SPONSOR OR EXHIBIT

Remaining marketing opportunities for world class solution providers are selling fast.
Contact: Michael.Hodge@terrapinn.com

GET THE SPONSORSHIP
& EXHIBITION BROCHURE

“Very well presented conference, excellent speakers and I gained a lot of insight and knowledge. Excellent networking opportunities with new and existing contacts.”

- Genesis Research Services

“The event brought together some of the most innovative and driven professionals in the industry, creating an inspiring space for collaboration, scientific exchange, and meaningful connections.”

- Omnicure Clinical Research

“The meetings were outstanding. This is the best meeting of the year for us. The start-up zone is amazing. The talks are timely and on-point and it is a great networking meeting.”

- Microbiologics Inc.

“This is an incredibly valuable conference for learning about the state of the vaccine industry.“

- Merck

“Hard to imagine how anyone could do more brilliantly. This year’s meeting was especially meaningful.”

- Peter Hotez, Professor, Baylor College of Medicine

R&D + Strategic Partnering
for the Global Vaccine Industry

WORLD’S LEADING VACCINE EVENT

4,000+

550+

300+

100+

4

12

15

2,500+

The Most Important Vaccine Event of The Year

The Start-to-Finish of Vaccines

From research, immune profiling & clinical trials to manufacture and access

EARLY CONFIRMED 2026 SPEAKERS

2026 Early Confirmed Sponsors and Exhibitors

Created by

R&D + Strategic Partnering for the Global Vaccine Industry

WORLD’S LEADING VACCINE EVENT

4,000+

550+

300+

100+

4

12

15

2,500+

The Most Important Vaccine Event of The Year

The Start-to-Finish of Vaccines

From research, immune profiling & clinical trials to manufacture and access

EARLY CONFIRMED 2026 SPEAKERS

2026 Early Confirmed Sponsors and Exhibitors

Created by

R&D + Strategic Partnering
for the Global Vaccine Industry